reports
DSV, 1111 - SHARE BUYBACK IN DSV A/S
DSV, 1111 - SHARE BUYBACK IN DSV A/S Company Announcement No. 1111 On 24 April 2024, we initiated a share buyback programme, as described in Company Announcement No. 1104. According to the programme, the company will in the period from 24 April 2024 until 23 July 2024 purchase own shares up to a maximum value of DKK 1,000 million, and no more than 1,700,000 shares, corresponding to 0.79% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (“MAR”) (save fo...
Nationgate Holdings Berhad: 2 directors
Two Directors at Nationgate Holdings Berhad sold 680,000 shares at between 1.844MYR and 1.853MYR. The significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
Dätwyler Holding AG: 1 director
A director at Dätwyler Holding AG sold 1,000 shares at 201.000CHF and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Rakta Paper Manufacturing: 1 director
A director at Rakta Paper Manufacturing bought 103,804 shares at 0.000EGP and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Malaysian Pacific Industries Berhad: 1 director
A director at Malaysian Pacific Industries Berhad sold 138,000 shares at 38.171MYR and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
HCK Capital Group Berhad: 1 director
A director at HCK Capital Group Berhad bought 1,950,000 shares at 2.140MYR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Gamuda Berhad: 4 directors
Four Directors at Gamuda Berhad sold 125,000 shares at between 5.621MYR and 5.930MYR. The significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
BNP Paribas Bank Polska S.A.: 1 director
A director at BNP Paribas Bank Polska S.A. sold 4,495 shares at 94.000PLN and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Kinergy Advancement Berhad: 1 director
A director at Kinergy Advancement Berhad sold 15,600,000 shares at 0.320MYR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Pr...
SAN FRANCISCO--(BUSINESS WIRE)-- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the EASL Congress has changed the Company’s Phase 2 SOLSTICE hepatitis delta presentation from a late-breaker poster to an oral presentation. The SOLSTICE data will be presented on June 8 during the annual meeting of the European Association for the Study of the Liver, EASL™ Congress 2024, taking place in Milan, Italy, June 5-8. The Company plans to host an investor conference call to discuss the new SOLSTICE data on June 5. The update will include data on participants that have reached 12 and 24 weeks of ch...
- Pierre FerraguÊ
Bible 1Q24 – Semicap: recovery on track, positive 2025 outlook in expe...
Today, we are publishing the Semicap section of our 23rd Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 130 companies we track, providing an update on our key perspectives and convictions. In the coming weeks we will publish sections on Automotive, Cloud Infrastructure, Telecom Equipment, Industrials, PCs, Enterprise IT, and Ride sharing & Delivery. Semicap equipment revenues were in line wi...
BYD’s Official Dealership in Mexico, Owned and Operated by Grupo Fame,...
BYD’s Official Dealership in Mexico, Owned and Operated by Grupo Fame, Selects Blink Charging for EV Charging Products and Services Grupo Fame’s dealership location in Querétaro, Mexico, now features Blink Level 2 chargers on site, with DC fast chargers utilizing GBT ports coming soon. Bowie, Md., May 21, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, today announced it has been selected by official BYD dealership group, Grupo Fame, one of the larg...
Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Office...
Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer SAN MATEO, Calif. and CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by deregulated transcription, today announced that it has appointed Deborah Knobelman, Ph.D., as Chief Operating Officer and Chief Financial Officer effective June 3, 2024. Dr. Knobelman will oversee the finance, accounting, business development, investor relations and corporate...
CI Financial Corp. Announces Private Offering of U.S. Dollar Notes
TORONTO--(BUSINESS WIRE)-- CI Financial Corp. (“CI” or the “Company”) (TSX: CIX) today announced that it intends, subject to market and other conditions, to offer and sell (the “Offering”) in a private placement to eligible purchasers a series of its senior unsecured U.S.-dollar-denominated notes (the “Notes”). Concurrently with the Offering, CI commenced a tender offer (the “Tender Offer”) to purchase for cash any and all of its outstanding 4.100% Notes due 2051 (the “2051 Notes”). The Tender Offer is being made only by and pursuant to the terms of the related Offer to Purchase. CI’s purcha...
GoldenPeaks Capital and Reckitt have signed a 10-year Power Purchase A...
GoldenPeaks Capital Holding Ltd. / Key word(s): Agreement GoldenPeaks Capital and Reckitt have signed a 10-year Power Purchase Agreement in Poland. 21.05.2024 / 14:00 CET/CEST Warsaw, May 21, 2024 - GoldenPeaks Capital and Reckitt have signed a 10-year Power Purchase Agreement in Poland, promoting further decarbonization of the country’s grid and helping Reckitt meet its green goals. GoldenPeaks Capital, one of the fastest growing independent power producers in Eastern Europe, continues its mission to help corporates in their carbon reduction efforts. The power purchase agr...
GoldenPeaks Capital und Reckitt haben in Polen einen Stromabnahmevertr...
GoldenPeaks Capital Holding Ltd. / Schlagwort(e): Vereinbarung GoldenPeaks Capital und Reckitt haben in Polen einen Stromabnahmevertrag mit einer Laufzeit von 10 Jahren unterzeichnet. 21.05.2024 / 14:00 CET/CEST Warschau, 21. Mai 2024 – GoldenPeaks Capital und Reckitt haben in Polen einen Stromabnahmevertrag mit einer Laufzeit von 10 Jahren unterzeichnet, der die weitere Dekarbonisierung des Stromnetzes des Landes vorantreibt und Reckitt dabei hilft, seine grünen Ziele zu erreichen. GoldenPeaks Capital, einer der am schnellsten wachsenden unabhängigen Stromerzeuger in Osteu...
Kalray Debuts Ngenea® for AI, a Data Acceleration Platform for GenAI a...
GRENOBLE, France & LAS VEGAS--(BUSINESS WIRE)-- Kalray (Euronext Growth Paris: ALKAL), a technology innovator building software and hardware solutions that accelerate data-intensive workflows, announced Ngenea® for AI, a new edition of its Kalray Data Acceleration Platform specifically fine-tuned for AI data pipelines. As AI demands new ways to ingest and access massive volumes of data, Ngenea for AI helps teams speed up performance, simplify data management and open their data assets to new AI-powered use cases. Ngenea for AI is the companion to two Ngenea editions for Media & Entertainment...
- Gary Brode
Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrat...
Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announces data from a poster presented at Digestive Disease Week (DDW2024) demonstrating the potential of the Company’s lead clinical-stage compound, FXR314, in combination with tofaciti...
Pyxis Tankers Announces Joint Venture Agreement to Acquire Modern Dry-...
Pyxis Tankers Announces Joint Venture Agreement to Acquire Modern Dry-Bulk Vessel, Expansion of Common Share Repurchase Program & Partial Redemption of Series A Cumulative Convertible Preferred Stock Maroussi, Greece – May 21, 2024 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an international shipping company, announced today key strategic and financial actions to further enhance its shareholder value. The Company has entered into an agreement with a group of sellers, including the Company’s Chairman and Chief Executive Officer, Mr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.